- Presentations
- 2
- Markets
- 1
Garzulys is a brand of Insulin aspart marketed by Meitheal Pharmaceuticals, with 2 presentations listed and registered in United States. Each presentation below has its own page with packs, documents and availability for export supply from India.
- Active ingredient (INN)
- Insulin aspart
- Brand owner
- Meitheal Pharmaceuticals
- Registered in
- United States
- Strengths and forms
- 100 IU/mL injection
All presentations
| Medicine | Manufacturer | Register | Availability |
|---|---|---|---|
| Garzulys 100 IU/mL injectionIntravenous, subcutaneous Cold chain | Meitheal Pharmaceuticals | US FDA | Available on request |
| Garzulys 100 IU/mL injectionSubcutaneous Cold chain | Meitheal Pharmaceuticals | US FDA | Available on request |
Equivalent brands
Other brands of Insulin aspart.
Brand names and trademarks belong to their owners and are used only to identify products.
Request Garzulys
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.